Comparative Efficacy of AXS-07 vs. Gepants for Acute Treatment of Migraine: A Network Meta-Analysis (P10-12.006)
To compare the efficacy of AXS-07 with gepants (rimegepant, ubrogepant, zavegepant) approved for acute migraine treatment in the United States using a network meta-analysis (NMA).
Authors
- Yang Zhao (ORCID: https://orcid.org/0000-0002-8303-3961)
- Christopher N. Graham (ORCID: https://orcid.org/0000-0001-8165-7095)
- Stephanie J. Nahas (ORCID: https://orcid.org/0000-0001-8846-8393)
- Andrew Blumenfeld (ORCID: https://orcid.org/0000-0003-0851-4914)
- Amanda Erbe (ORCID: https://orcid.org/0000-0001-7072-6761)
Institutions
- Thomas Jefferson University (US)
- Pain and Headache Center (US)
- Axsome Therapeutics (United States) (US)
- RTI Health Solutions (US)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000210541
- Primary Topic
- Migraine and Headache Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00